Global Liquid Biopsy Market

By Author: bis
Total Articles: 68
Comment this article

According to a new market intelligence report by BIS Research titled ‘Global Liquid Biopsy Market – Analysis and Forecast, 2020-2030’, The liquid biopsy market is projected to reach $12,933 million by 2030 from $2588.6 million in 2019, at a CAGR of 15.87% during the forecast period 2020-2030

BIS Research Report: https://bisresearch.com/industry-report/global-liquid-biopsy-market.html

This growth has been primarily attributed to the rising number of cancer cases coupled up with the growing awareness pertaining to non-invasive detection approaches, the increasing adoption of inorganic growth strategies by key players in the market, and the increasing research funding from the leading organizations such as the U.S. National Institute of Health, globally.

The market is expected to grow at a significant growth rate due to opportunities such as the introduction of informatics and technological innovations for a large customer base and increasing adoption of cancer and other diseases testing services.

Request for Sample: https://bisresearch.com/requestsample?id=982&type=download

...
... However, there are significant challenges that are restraining the market growth. These challenges include false negatives and positives, limited and ambiguous reimbursement scenario, expected implementation of Patient Protection and Affordable Care (PPACA) Act (for research used kits and consumables), and existing diagnostic confidence of medical community on liquid biopsy procedures. Despite the substantial investments made by the conglomerate companies of the healthcare industry, the clinical application of liquid biopsy is predominantly limited to treatment monitoring, however adoption is expected to increase owing to the recent approval of GUARDANT360. Several factors such as low confidence of the physicians, uncertainty pertaining to approval scenario, and a lack of favorable reimbursement policies are the leading factors hampering the growth of the global liquid biopsy market.

Key Questions Answered in the Report
§ What are the major market drivers, challenges, and opportunities in the global liquid biopsy market?

§ What are the key development strategies which are implemented by the major players to sustain in the competitive market?

§ Which is the dominant product type developed by the leading and emerging players for liquid biopsy?

§ What are the key technologies that have been used by leading players in the global liquid biopsy market for the development of diagnostic and research solutions for cancer?

§ How each segment of the market is expected to grow during the forecast period from 2020 to 2030?